Pateclizumab
Modify Date: 2024-04-06 17:13:29
Pateclizumab structure
|
Common Name | Pateclizumab | ||
|---|---|---|---|---|
| CAS Number | 1202526-59-7 | Molecular Weight | N/A | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | N/A | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of PateclizumabPateclizumab (MLTA3698A) is a humanized antibody against lymphotoxin α (LTα), a transiently expressed cytokine on activated B and T cells (Th1, Th17), which are implicated in rheumatoid arthritis (RA) pathogenesis[1]. |
| Name | Pateclizumab |
|---|
| Description | Pateclizumab (MLTA3698A) is a humanized antibody against lymphotoxin α (LTα), a transiently expressed cytokine on activated B and T cells (Th1, Th17), which are implicated in rheumatoid arthritis (RA) pathogenesis[1]. |
|---|---|
| Related Catalog | |
| Target |
lymphotoxin α |
| References |
| No Any Chemical & Physical Properties |